Calprotectin Elisa test (ALP/HRP)

Calprotectin ELISA Test (ALP/HRP)


The CALPRO Calprotectin ELISA Test (ALP/HRP) is a quantitative method for the determination of Calprotectin in stool samples and can be used as an aid in identifying organic disease of the small intestine, large bowel or the stomach in patients, to determine the disease activity and monitor the response to treatment in patients with ulcerative colitis or Crohn’s disease. In the literature Calprotectin determination has also be done in other body fluids, secretions and excretions, for instance serum, plasma or urine. The Calprotectin concentrations and protocols vary and have to be performed according to the published methods (e.g., Johne et al., 1997). The CALPRO Calprotectin ELISA Test (ALP) has only been validated for stool samples. In patients under treatment a normal Calprotectin value is an indicator that mucosal healing has been achieved. The test can also be used to predict clinical relapses. Functional disorders like irritable bowel disease, do not give increased fecal Calprotectin concentrations.




  • Anne Thjømøe

    Executive Chairman 


    Direct line: +47 97 73 37 51

  • Anne Hancke Framstad

    Laboratory Quality Specialist


    Direct line: +47 92 01 14 91

  • Einar Mørk

    Dir. Operations


    Direct line: +47 47 28 55 61

  • Mona Schartum

    Production Manager


    Direct line: +47 93 22 73 63

  • Ingvild haukø bilde

    Ingvild Haukø

    Sales- and Marketing Manager


    Direct line: +47 92 01 52 18

  • Ali Qamar

    Product Manager


    Direct line: +47 41 17 81 19

General Information

Fecal calprotectin in differential diagnosis of irritable bowel syndrome

Li XG, Lv YM, Gu F, Yang XL., Department of Gastroenterology, Peking University Third May 9, 2015

Latest News

Calpro press release regarding MSD agreement

Please see the Calpro press release regarding MDS agreement for delivery of e-health technology CalproSmart:

Norsk | English October 13, 2016

View all latest

Share This